Business Description
Celcuity Inc
NAICS : 541714
SIC : 2834
ISIN : US15102K1007
Description
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.72 | |||||
| Equity-to-Asset | 0.55 | |||||
| Debt-to-Equity | 0.65 | |||||
| Debt-to-EBITDA | -1.14 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -40.7 | |||||
| 3-Year EPS without NRI Growth Rate | -43 | |||||
| 3-Year FCF Growth Rate | -47.8 | |||||
| 3-Year Book Growth Rate | 69 | |||||
| Future 3-5Y EPS without NRI Growth Rate | -6.7 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36.64 | |||||
| 9-Day RSI | 36.16 | |||||
| 14-Day RSI | 37.2 | |||||
| 6-1 Month Momentum % | 7.21 | |||||
| 12-1 Month Momentum % | 7.79 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 10.36 | |||||
| Quick Ratio | 10.36 | |||||
| Cash Ratio | 10.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -35.3 | |||||
| Shareholder Yield % | -6.54 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -67.82 | |||||
| ROA % | -43.21 | |||||
| ROIC % | -8182.17 | |||||
| ROC (Joel Greenblatt) % | -13484.4 | |||||
| ROCE % | -42.87 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 3.17 | |||||
| Price-to-Tangible-Book | 3.18 | |||||
| EV-to-EBIT | -3.6 | |||||
| EV-to-EBITDA | -3.61 | |||||
| EV-to-FCF | -4.14 | |||||
| Price-to-Net-Current-Asset-Value | 3.18 | |||||
| Price-to-Net-Cash | 3.38 | |||||
| Earnings Yield (Greenblatt) % | -27.78 | |||||
| FCF Yield % | -15.67 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CELC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Celcuity Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.6 | ||
| Beta | -0.3 | ||
| Volatility % | 56.66 | ||
| 14-Day RSI | 37.2 | ||
| 14-Day ATR ($) | 0.824306 | ||
| 20-Day SMA ($) | 14.0815 | ||
| 12-1 Month Momentum % | 7.79 | ||
| 52-Week Range ($) | 11.51 - 22.188 | ||
| Shares Outstanding (Mil) | 37.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Celcuity Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Celcuity Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Celcuity Inc Frequently Asked Questions
What is Celcuity Inc(CELC)'s stock price today?
The current price of CELC is $12.80. The 52 week high of CELC is $22.19 and 52 week low is $11.51.
When is next earnings date of Celcuity Inc(CELC)?
The next earnings date of Celcuity Inc(CELC) is 2025-02-14 Est..
Does Celcuity Inc(CELC) pay dividends? If so, how much?
Celcuity Inc(CELC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers